Skip to main content
Disciplines
Automotive Business IT + Informatics Construction + Real Estate Electrical Engineering + Electronics Energy + Sustainability Insurance + Risk Finance + Banking Management + Leadership Marketing + Sales Mechanical Engineering + Materials
Events
DE
EN
Books
Journals
Topic Page
Marketing
Start single access now
Access for companies
EXTENDED SEARCH
Log in
Top
Published in:
Introduction Read chapter Read first chapter

2020 | OriginalPaper | Chapter

Emerging Life Sciences: New Challenges to Strategic Stability

Author : Margaret E. Kosal

Published in: Disruptive and Game Changing Technologies in Modern Warfare

Publisher: Springer International Publishing

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

This chapter explores the potential for new biotechnologically-enabled weapons to compete with nuclear weapons as far as effect on strategic stability, and assesses whether the assumptions in traditional strategic stability models are still valid when applied to such scenarios, and how changing capabilities and adversaries may shape approaches to arms control, verification, and monitoring. When thinking about biotechnology from a security perspective, anticipating the types of security threats that may emerge as science and technology advance, the potential consequences of those threats, the probability that adversaries will obtain or pursue them, adversarial intent, and potential effect on strategic stability is necessary. The range and spectrum of possible capabilities and actors are expanding. The most recent addition to the genome-editing arsenal is CRISPR, a bacteria-derived system that is among the simplest genome-editing tools. The CRISPR-Cas9 system—and emerging variants on the system—enables unprecedented control and ease when editing the genome. With parallels to remote ‘command and control’ of the genome, this is one aspect that makes the technology different from earlier gene-editing methods. Contemporary analyses of emerging technologies often expose tenuous links or disconnections between technical realities and mainstream scholarship. How, when, where, and in what form the shifting nature of technological progress may bring enhanced or entirely new capabilities, many of which are no longer the exclusive domain of a single nation-state, is contested and requires better analytical tools to enable assessment and inform policy choices. This work is hardly the only one to consider the biosecurity implications of CRISPR, gene-editing, and broader issues of biotechnology. As far as is known, it is the only one to address these emerging life sciences technologies in the context of nuclear strategic stability and implications for balance of power, arms control, and international security.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

inform now
previous chapter Game-Changing Military Technologies: Adoption and Governance
next chapter Additive Manufacturing (AM) and WMD Proliferation
Footnotes
1
“New scientific and technological developments relevant to the Convention: Some examples,” BWC Preparatory Committee, Eighth Review Conference of the States Parties to the Convention on the Prohibition of the Development, Production and Stockpiling of Bacteriological (Biological) and Toxin Weapons and on Their Destruction, BWC/CONF.VIII/PC/WP.18, August 5, 2016.
 
2
For example, see [10‐14].
 
3
For an excellent overview of the CRISPR-Cas9 system by two of the discovers, see [31].
 
Literature
1.
Rennstich KJ (2008) The making of a digital world: the evolution of technological change and how it shaped our world. Palgrave MacMillan, New YorkCrossRef
2.
3.
Biotechnology Research in an Age of Terrorism. National Academies Press, Washington, D.C. (2004)
4.
Globalization, Biosecurity, and the Future of the Life Sciences. National Academies Press, Washington, D.C. (2006)
5.
6.
7.
8.
Reeves RG et al (2018) Agricultural research, or a new bioweapon system? Science 362(6410):35–37CrossRef
9.
10.
Vogel KM, Ouagrham-Gormley SB (2018) Anticipating emerging biotechnology threats: a case study of CRISPR. Polit Life Sci 37(2):203–219CrossRef
11.
Gronvall G (2018) The security implications of synthetic biology. Survival 60(4):165–180CrossRef
12.
13.
Koblentz GD (2004) Pathogens as weapons: the international security implications of biological warfare. Int Secur 29(1):84–122CrossRef
14.
Peterson S (2002) Epidemic disease and national security. Secur Stud 12(2):43–81CrossRef
15.
Elbe S (2002) HIV/AIDS and the changing landscape of war in Africa. Int Secur 27(2):159–177CrossRef
16.
McInnes C, Lee Kelley (2006) Health, security and foreign policy. Rev Int Stud 32:5–23CrossRef
17.
Letendre K, Fincher CL, Thornhill R (2010) Does infectious disease cause global variation in the frequency of intrastate armed conflict and civil war? Biol Rev 85(3):669–683
18.
Waddington C (2014) Ebola outbreak in Guinea: a different type of regional stability threat. Africa Confl Monthly Monit 2014(5):47–51
19.
Heymann DL et al (2015) Global health security: the wider lessons from the west African Ebola virus disease epidemic. Lancet 385(9980):1805–1806CrossRef
20.
Omoleke SA, Mohammed I, Saidu Y (2016) Ebola viral disease in West Africa: a threat to global health, economy and political stability. J Public Health Africa 7(1):27–40
21.
Kalra S et al (2014) The emergence of Ebola as a global health security threat: from ‘Lessons Learned’ to coordinated multilateral containment efforts. J Glob Infect Dis 6(4): 164–177
22.
Jackson RJ et al (2001) Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. J Virol 75:1205–1210CrossRef
23.
Chen N et al (2011) Poxvirus interleukin-4 expression overcomes inherent resistance and vaccine-induced immunity: pathogenesis, prophylaxis, and antiviral therapy. Virology 409(2):328–337CrossRef
24.
25.
Guerra FM et al (2017) The basic reproduction number (R0) of measles: a systematic review. Lancet 17(12):e420–e428CrossRef
26.
Fine PE (1993) Herd immunity: history, theory, practice. Epid Rev 15:265–302CrossRef
27.
Wallinga J, Lévy-Bruhl D, Gay NJ, Wachmann CH (2001) Estimation of measles reproduction ratios and prospects for elimination of measles by vaccination in some western European countries. Epid Infect 127:281–295CrossRef
28.
Porteus M (2006) Mammalian gene targeting with designed zinc finger nucleases. Mol Ther 13:438–446CrossRef
29.
Mansilla-Soto J, Riviere I, Boulad F et al (2016) Cell and gene therapy for the beta-thalassemias: advances and prospects. Hum Gene Ther 27(4): 295–304CrossRef
30.
Jo Yi, Kim H, Ramakrishna S (2015) Recent developments and clinical studies utilizing engineered zinc finger nuclease technology. Cell Mol Life Sci 72(20):3819–3830CrossRef
31.
Doudna JA, Charpentier E (2014) The new frontier of genome engineering with CRISPR-Cas9. Science 346(6213):1077–1088CrossRef
32.
Ran FA et al (2015) In vivo genome editing using Staphylococcus aureus Cas9. Nature 520:186–191CrossRef
33.
Zetsche B et al (2015) Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-cas system. Cell 163(3):759–771CrossRef
34.
Fonfara I et al (2016) The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA. Nature 532:517–521CrossRef
35.
McKenna A et al (2016) Whole organism lineage tracing by combinatorial and cumulative genome editing. Science 353(6298):aaf7907-11CrossRef
36.
Yoshimi K, Kaneko T, Voigt B, Mashimo T (2014) Allele-specific genome editing and correction of disease-associated phenotypes in rats using the CRISPR-cas platform. Nat Commun 5(4240):1–9
37.
Heo TY et al (2015) CRISPR/Cas9 nuclease-mediated gene knock-in in bovine-induced pluripotent cells. Stem Cells Dev 24:393–402CrossRef
38.
Han H et al (2014) One-step generation of myostatin gene knockout sheep via the CRISPR/Cas9 system. Front Agric Sci Eng 1: 2–15
39.
40.
41.
Liang P et al (2015) CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein Cell 6(5):363–372CrossRef
42.
Cyranoski D, Reardon S (2015) Embryo editing sparks epic debate. Nature 520:593–595CrossRef
43.
Normile D (2018) Shock greets claim of CRISPR-edited babies. Science 362(6418):978–979CrossRef
44.
45.
46.
O’Green H, Abigail S, Sega DJ (2015) How specific is CRISPR/Cas9 really?. Curr Opin Chem Biol 29:72–78
47.
Tsai SQ et al (2015) GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol 33:187–197CrossRef
48.
Chapman JE, Gillum D, Kiani S (2017) Approaches to reduce CRISPR off-target effects for safer genome editing. Appl Biosaf J ABSA Int 22(1):7–13CrossRef
49.
50.
Wei X, Nielsen R (2019) CCR52-∆32 is deleterious in the homozygous state in humans. Nat Med 25:909–910CrossRef
51.
Zhou M et al (2016) CCR5 is a suppressor for cortical plasticity and hippocampal learning and memory. eLife 20(5):e20985
52.
Joy MT et al (2019) CCR54 is a therapeutic target for recovery after stroke and traumatic brain injury. Cell 176(5):1143–1157CrossRef
53.
54.
55.
Martin S (2002) The role of biological weapons in international politics: the real military revolution. J Strateg Stud 25(1):76
56.
57.
58.
Kosal ME (2018) WMD strategy gap: capacities, capabilities, and collaboration. PRISM 7(3):50–67
59.
Smithson Amy E (1999) Tall order: crafting a meaningful verification protocol for the biological weapons convention. Polit Life Sci 18(1):79–85CrossRef
60.
Littlewood J (2005) The biological weapons convention: a failed revolution. Ashgate Publishing, Aldershot
61.
Littlewood J (2012) The biological weapons convention. In: Faure G (ed) Unfinished business: why international negotiations fail. University of Georgia Press, Athens, pp 107–129
62.
63.
Hart J, Trapp R (2012) Science, technology, and the biological weapons convention. Arms Control Today 42(8):15–21
64.
65.
Tebas P et al (2014) Gene editing of CCR68 in autologous CD4 T cells of persons infected with HIV. N Engl J Med 370:901–910CrossRef
66.
Flotte TR (2015) Therapeutic germ line alteration: has CRISPR/Cas9 technology forced the question? Hum Gene Ther 26(5):245–246CrossRef
67.
68.
69.
Kosal ME (2009) Nanotechnology for chemical and biological defense. Springer Academic Publishers, New YorkCrossRef
70.
Ostfield M (2009) Pathogen security: the illusion of security in foreign policy and biodefense. Int J Risk Assess Manag 12:204–221CrossRef
71.
72.
Metadata
Title
Emerging Life Sciences: New Challenges to Strategic Stability
Author
Margaret E. Kosal
Copyright Year
2020
Book
Disruptive and Game Changing Technologies in Modern Warfare

Print ISBN: 978-3-030-28341-4

Electronic ISBN: 978-3-030-28342-1

Copyright Year: 2020

DOI
https://doi.org/10.1007/978-3-030-28342-1_3

Premium Partner

    Image Credits